First pill for dengue shows promise in human challenge trial Roshni Dhar23 Oct 2023 3:30 PM ISTA pill for dengue fever developed by Johnson & Johnson appeared to protect against a form of the virus in a handful of patients in a small human...
First dengue pill shows promise in human challenge trial Ruchika Sharma21 Oct 2023 4:58 PM ISTNew Delhi: A pill for dengue fever developed by Johnson & Johnson appeared to protect against a form of the virus in a handful of patients in a...
JnJ embarks on two year restructuring program for orthopedics business Ruchika Sharma19 Oct 2023 12:25 PM ISTNew Jersy: Johnson & Johnson has said it has embarked on a two-year restructuring program for its orthopedics business after third-quarter...
Indian Pharma cos get green signal to distribute generic Bedaquiline in low, middle income countries Ruchika Sharma3 Oct 2023 3:30 PM ISTNew Delhi: Indian pharmaceutical manufacturers have received a green light to distribute the generic anti-TB drug Bedaquiline to other countries...
JnJ, P&G, Walgreens accused in lawsuits over cold medicine decongestant Ruchika Sharma15 Sept 2023 2:30 PM ISTJohnson & Johnson, Procter & Gamble and Walgreens are among several companies accused in lawsuits of deceiving consumers about cold...
Janssen declares positive topline results from Phase 3 study evaluating RYBREVANT given with, without lazertinib combined with chemotherapy versus chemotherapy alone Ruchika Sharma9 Sept 2023 1:45 PM ISTNew Jersey: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced positive topline results from the three-arm Phase 3 ...
Johnson & Johnson to halt hypertension drug Macitentan study Ruchika Sharma8 Sept 2023 11:43 AM ISTThe study was deemed "futile" and failed to improve exercise capacity in a broad population including inoperable patients compared to a placebo, J&J...
Janssen seeks USFDA full approval for Balversa for Urothelial Carcinoma Ruchika Sharma1 Sept 2023 12:30 PM ISTRaritan: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a supplemental New Drug Application...
Lupin, JnJ cut prices for TB drug in lower-income countries Ruchika Sharma1 Sept 2023 11:30 AM ISTThe drug will be available at the lower prices through the Stop TB Partnership's Global Drug Facility, which is the largest procurer of TB treatments.
CDSCO panel tells JnJ to submit clarification for weight based calculated fixed dose of Teclistamab Isra Zaman23 Aug 2023 12:54 PM ISTBased on the proposal presented by drug major Johnson & Johnson for the protocol amendment of the anticancer drug Teclistamab, the Subject Expert...
Health Bulletin 22/August/2023 Isra Zaman22 Aug 2023 4:24 PM ISTHere are the top health stories for the day:Rural, urban health training center mandatory for starting new medical college: NMC regulationsThe...
European Commission nod to reduced dosing frequency for Janssen Tecvayli Ruchika Sharma20 Aug 2023 11:30 AM ISTTeclistamab is an off-the-shelf (or ready to use) bispecific antibody.
